Targeting Interleukin-2-Inducible T-Cell Kinase (ITK) Differentiates GVL and GVHD in Allo-HSCT.
Mammadli M, Huang W, Harris R, Sultana A, Cheng Y, Tong W, Pu J, Gentile T, Dsouza S, Yang Q, Bah A, August A, Karimi M.
Mammadli M, et al. Among authors: gentile t.
Front Immunol. 2020 Nov 26;11:593863. doi: 10.3389/fimmu.2020.593863. eCollection 2020.
Front Immunol. 2020.
PMID: 33324410
Free PMC article.